The recall includes all implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) with a glassed feedthrough manufactured after 2017. The FDA has categorized this as a Class I recall, meaning the use of these devices “may cause serious injuries or death.”
